Earnings Summary

Mesa Laboratories Inc’s revenue jumped 4.56% since last year same period to $26.29Mn in the Q2 2019. On a quarterly growth basis, Mesa Laboratories Inc has generated -0.6% fall in its revenue since last 3-months.

Mesa Laboratories Inc’s net profit jumped 8.68% since last year same period to $4.6Mn in the Q2 2019. On a quarterly growth basis, Mesa Laboratories Inc has generated 227.89% jump in its net profits since last 3-months.

Mesa Laboratories Inc’s net profit margin jumped 3.94% since last year same period to 17.49% in the Q2 2019. On a quarterly growth basis, Mesa Laboratories Inc has generated 229.86% jump in its net profit margins since last 3-months.

Mesa Laboratories Inc’s earning per share (EPS) estimates for the current quarter stand at 0.14 - a 145.16% jump from last quarter’s estimates.

Mesa Laboratories Inc’s earning per share (EPS) estimates for the current year stand at 0.14.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Mesa Laboratories Inc’s return on assets (ROA) stands at 0.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Mesa Laboratories Inc’s return on equity (ROE) stands at -0.

Mesa Laboratories Inc declared 0.16 dividend per share during the earnings announcement for Q4 2022.